Celltrion Pharm, Inc. (068760.KQ)

KRW 61300.0

(-3.01%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 641.64 Billion 599.72 Billion 637.88 Billion 548.07 Billion 470.98 Billion 452.44 Billion
Total Current Assets 364.83 Billion 311.91 Billion 331.13 Billion 230.95 Billion 188.85 Billion 199.96 Billion
Cash And Short Term Investments 37.13 Billion 49.06 Billion 88.16 Billion 29.74 Billion 13.33 Billion 9.11 Billion
Cash and Cash Equivalents 19.71 Billion 31.39 Billion 80.18 Billion 25.74 Billion 10.76 Billion 9.11 Billion
Short Term Investments 17.42 Billion 17.67 Billion 7.97 Billion 4 Billion 2.56 Billion -
Net Receivables 222.49 Billion 187.6 Billion 174 Billion 142.01 Billion 139.46 Billion 142.86 Billion
Inventory 100.42 Billion 69.17 Billion 63.88 Billion 55.01 Billion 33.1 Billion 42.01 Billion
Other Current Assets 4.77 Billion 6.06 Billion 5.08 Billion 4.17 Billion 2.95 Billion 5.96 Billion
Total Non-Current Assets 276.81 Billion 287.8 Billion 306.74 Billion 317.12 Billion 282.12 Billion 252.48 Billion
Net PPE 220.76 Billion 228.24 Billion 241.92 Billion 248.25 Billion 216.57 Billion 195.55 Billion
Good Will And Intangible Assets 39.29 Billion 41.32 Billion 39.42 Billion 38.05 Billion 35.15 Million 35.01 Million
Good Will 32.91 Billion 32.91 Billion 32.91 Billion 32.91 Billion 32.91 Billion 32.91 Billion
Intangible Assets 6.37 Billion 8.41 Billion 6.51 Billion 5.13 Billion 2.24 Million 2.1 Million
Long-Term Investments 1.5 Billion 1.57 Billion 2.12 Billion 2.05 Billion 3.17 Billion 2.62 Billion
Tax Assets 10.79 Billion 12.54 Billion 13.17 Billion 17.6 Billion 15.65 Billion 18.07 Billion
Other Non Current Assets 4.45 Billion 4.12 Billion 10.09 Billion 11.14 Billion 46.67 Billion 36.19 Billion
Other Assets 1.00 - - - - -
Total Liabilities 264.97 Billion 242.93 Billion 302.91 Billion 244.51 Billion 187.94 Billion 179.4 Billion
Total Current Liabilities 249.34 Billion 211.99 Billion 259.91 Billion 184.92 Billion 149.13 Billion 145.03 Billion
Account Payables 59.27 Billion 38.07 Billion 72.59 Billion 21.61 Billion 6.8 Billion 12.37 Billion
Tax Payables 2.01 Billion 5.63 Billion 1.7 Billion 754.92 Million 315.3 Million -
Short Term Debt 156.66 Billion 138.87 Billion 141.63 Billion 135.17 Billion 123.07 Billion 112.6 Billion
Deferred Revenue 567.02 Million 521.33 Million 13.35 Billion 450.26 Million 580.72 Million 621.78 Million
Other Current Liabilities 32.83 Billion 34.52 Billion 32.32 Billion 27.69 Billion 18.67 Billion 19.43 Billion
Total Non Current Liabilities 15.63 Billion 30.93 Billion 43 Billion 59.58 Billion 38.81 Billion 34.37 Billion
Long-Term Debt 4.33 Billion 21.66 Billion 38.99 Billion 57.26 Billion 38.6 Billion 34.37 Billion
Deferred Revenue Non Current 8.71 Billion 8.23 Billion 2.62 Billion 879.1 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.05 Billion 885.06 Million 978.66 Million 857.21 Million 207.51 Million -
Other Liabilities - 1.00 1.00 1.00 - -
Total Equity 376.66 Billion 356.78 Billion 331.96 Billion 300.56 Billion 280.03 Billion 270.03 Billion
Stock Holders Equity 376.66 Billion 356.78 Billion 331.96 Billion 300.56 Billion 280.03 Billion 270.03 Billion
Common Stock 19.8 Billion 18.85 Billion 18.27 Billion 17.9 Billion 17.04 Billion 17.03 Billion
Retained Earnings 111.44 Billion 91.11 Billion 65.7 Billion 31.48 Billion 11.08 Billion -45.2 Billion
Accumulated other comprehensive income 7.58 Billion 5.53 Billion 3.32 Billion 2.59 Billion 2.67 Billion 1.63 Billion
Common Stock Equity 376.66 Billion 356.78 Billion 331.96 Billion 300.56 Billion 280.03 Billion 270.03 Billion
Capital Lease Obligation 1.52 Billion 156.42 Million 398.22 Million 586.58 Million 207.51 Million -
Total Investments 18.92 Billion 19.25 Billion 10.09 Billion 6.05 Billion 5.74 Billion 2.62 Billion
Total Debt 162.52 Billion 160.69 Billion 181.03 Billion 193.02 Billion 161.88 Billion 146.97 Billion
Net Debt 142.81 Billion 129.3 Billion 100.84 Billion 167.27 Billion 151.12 Billion 137.85 Billion

Balance Sheet Charts